This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on June 29, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
Acquisition of a Bio-Rad ChemiDoc Imaging System for the Genitourinary Malignancies Branch (NCI/CCR/GMB)
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health, through its Office of Acquisition and Logistics Management, intends to awarded a non-competitive contract to Bio-Rad Laboratories for the acquisition of a ChemiDoc Go Imaging System to support prostate cancer research within the Genitourinary Malignancies Branch of the National Cancer Institute. The system is required to replace a failed unit whose manufacturer has discontinued support, rendering repairs unfeasible; the new instrument will ensure uninterrupted critical workflows for over ten researchers performing chemiluminescent western blots and agarose gel imaging without necessitating retraining, additional space, or new accessories. This procurement is conducted under the Federal Acquisition Regulation Part 13 Simplified Acquisition Procedures, with a projected value not exceeding $350,000, and is classified under NAICS code 334516. The acquisition is authorized under FAR 13.106-1(b)(1) to justify single-source procurement due to the necessity of maintaining continuity with an identical, discontinued model. All interested parties may submit capability statements by July 9, 2026, to demonstrate their ability to fulfill the requirement, including technical and cost proposals, period of performance, Unique Entity ID, Taxpayer Identification Number, and business size certification. Submissions must be made electronically to the designated contracting officer and include active SAM registration; fax responses are not accepted. While the government reserves the right to proceed non-competitively based on the intent to award to Bio-Rad, responses from other sources will be evaluated to determine if competition is warranted. The procurement is not subject to competition requirements under FAR Part 6, and all submissions must reference solicitation number 75N98026Q00713. The contract will incorporate provisions from FAC 2026-01 and is being managed by the Office of Logistics and Operations at NIH in Bethesda, Maryland.
General Info
Agency
NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98026Q00713
Posted Date:
June 29, 2026
Original Response Date:
July 9, 2026
Current Response Date:
July 9, 2026
Set Aside:
N/A
NAICS Code:
334516
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
BIO-RAD LABORATORIES
2000 Alfred Nobel Drive
Hercules, CA 94547
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 334516 with a Size Standard $1000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2026-01, March 13, 2026. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: Acquisition of a Bio-Rad ChemiDoc Imaging System for the Genitourinary Malignancies Branch (NCI/CCR/GMB)
- Background Information: The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Genitourinary Malignancies Branch (GMB) requires the procurement of a Bio-Rad ChemiDoc Go Imaging System to support prostate cancer research. The GMB laboratories currently rely on the imaging system for visualization of chemiluminescent western blots and agarose gels. This system is no longer functional due to failure of the UV illumination drawer, and the manufacturer has discontinued support, making repair impossible. This instrument is used by over 10 researchers and is essential for routine laboratory workflows. Imaging of western blots and agarose gels is a fundamental requirement in modern molecular and cell biology research. Replacement with a newer model of the same system ensures continuity of operations without requiring retraining of staff, additional laboratory space, or replacement of compatible accessories such as sample trays and printers..
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.
All responses must be received by July 9, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00713. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
